Skip to the chapter
The care notebook

Sermorelin · a guide to finding care

Understand the drug

Can a pharmacy make it?

A pharmacy may be able to make it, but the ingredient and the maker matter. Ask the pharmacy to explain which rules cover your medicine.

Read the source notes

What is compounding?

With compounding, the patient’s medicine is made or mixed rather than supplied as a drug maker’s finished product.

As of September 2026, compounded drugs did not have FDA approval.

FDA is this notebook’s shorthand for the Food and Drug Administration, the agency that oversees US drugs.

FDA does not review a compounded product for safety, quality or whether it works before the product reaches the market.

Is there a route for sermorelin?

Sermorelin acetate is sermorelin paired with another substance to make a salt. This is the version used in the old approved medicine.

Under the rules checked in September 2026, a state-licensed pharmacy may prepare this version on a valid prescription for an individual named patient.

A licence is permission to practise; a prescription is an order for a medicine.

The pharmacy must also meet the other federal conditions and its state’s rules. The raw ingredient must come from an FDA-registered maker and have a document reporting its test results.

This possible route comes from reading the general ingredient rules. The records checked contained no FDA statement naming sermorelin as allowed for ordinary pharmacies.

These rules support saying a pharmacy may make sermorelin acetate if it meets all the conditions. They do not give the same answer for other versions of sermorelin.

Ask for the full ingredient name, including “acetate”. Ask the pharmacy how it meets the federal conditions and any extra limits in your state. Keep that answer with the maker’s name.

What if a larger facility makes it?

As of September 2026, FDA was still deciding whether to add sermorelin acetate to its final list of allowed raw ingredients for larger facilities.

The name for these businesses is outsourcing facilities. Their batches of medicine are sterile: they contain no living germs.

While deciding, FDA said it planned no action over a facility’s use of this ingredient, provided the facility met the guidance conditions.

That policy did not approve the medicine or put the ingredient on the final allowed list.

A larger facility must follow the drug-factory quality rules and is inspected by FDA.

Ask which conditions the facility relies on and how it meets them. This page cannot confirm that a particular maker meets every condition. If the answer stays unclear, keep the medicine check open.

Source notes for this chapter

Source check: September 2026.